| Type : |
Journal |
| Internett-koblingen : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=2464 |
|
| Forskerteamet : |
Houston - M.D.Anderson Cancer Center |
| Forfattere : |
Trissel LA, Zhang Y, Koontz SE. |
| Tittel : |
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions |
| Nummer : |
Int J Pharm Compound ; 10, 5: 396-399. 2006 |
|
| Nivå of Evidence : |
|
| Fysisk stabilitet : |
|
| Kjemisk stabilitet : |
|
| Andre metoder : |
|
| Kommentarer : |
|
Lister
 Temozolomide
|
 |
 |
 |
Povidon K30 |
 |
 |
 |
 |
 |
300 mg
Temodar® |
| Povidon K30 |
150 mg |
| Vannfri sitronsyre |
7.5 mg |
| Renset vann |
0.45 ml |
| OraPlus® |
15 ml |
| Orasweet® |
>> 30 ml |
|
4°C |
 |
| 60 |
 |
|
|
|
|
|
300 mg
Temodar® |
| Povidon K30 |
150 mg |
| Vannfri sitronsyre |
7.5 mg |
| Renset vann |
0.45 ml |
| OraPlus® |
15 ml |
| Orasweet SF ® |
>> 30 ml |
|
4°C |
|
| 60 |
|
|
|
|
|
